Why Farbe Firma is the Top Manufacturer of Citicoline Sodium Injection
- Maulik Sudani
- 1 hour ago
- 6 min read
Last Updated: May 25, 2026
TL;DR: Citicoline Sodium Injection — citicoline (cytidine-5'-diphosphocholine, better known as CDP-choline), the naturally occurring nucleotide that drives the biosynthesis of phosphatidylcholine, the principal phospholipid of the neuronal cell membrane, supplied as a clear sterile aqueous solution in ampoules and vials — is the neuroprotective parenteral clinicians reach for in acute ischaemic stroke, traumatic head injury and age-related cognitive impairment. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Citicoline Sodium Injection at our Gujarat, India facility and supplies it to hospital tenders, neurology and critical-care programmes, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Neuroprotective and nootropic agent — citicoline is an intermediate in the Kennedy pathway that rebuilds phosphatidylcholine in damaged neuronal membranes, stabilises membrane integrity after ischaemia and supports acetylcholine synthesis. It is used in acute ischaemic stroke, traumatic brain injury, post-stroke cognitive recovery and age-related memory disorders, and appears on numerous national neurology formularies.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, humidity-controlled handling of the hygroscopic active, qualified ampoule and vial filling lines and validated terminal moist-heat sterilisation with full container-closure integrity verification.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, drug master files and CEP-style documentation for registrations across regulated and emerging markets.
End-to-end CDMO services: Contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tender-ready packaging and logistics coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Citicoline Sodium Injection Demands a Premium Manufacturer
Citicoline Sodium Injection addresses one of the most time-critical problems in medicine: the survival of brain tissue after the blood supply is interrupted. Citicoline — cytidine-5'-diphosphocholine, an endogenous nucleotide better known as CDP-choline — is a rate-limiting intermediate in the Kennedy pathway, the metabolic route by which cells synthesise phosphatidylcholine, the dominant phospholipid of every neuronal membrane. When an ischaemic stroke or a traumatic head injury damages those membranes, free fatty acids and free radicals accumulate, membrane structure breaks down, and neurons that might still be salvageable are lost. Supplying citicoline parenterally feeds the repair pathway directly, helping rebuild membrane phospholipid, dampening the destructive cascade and supporting the synthesis of acetylcholine. For neurology and critical-care teams, a dependable parenteral citicoline supply is part of the early-intervention toolkit, not an optional extra.
That clinical urgency places real demands on the manufacturer. Citicoline Sodium Injection is given intravenously or intramuscularly — commonly as 250 mg/2 mL, 500 mg/4 mL and 1000 mg/4 mL presentations in ampoules and vials — so every container must deliver an accurate, uniform dose, often during the chaotic first hours of stroke management. The citicoline sodium active is markedly hygroscopic: it draws moisture from the air, and uncontrolled humidity during weighing and compounding undermines potency calculations and batch-to-batch consistency. The finished solution must be held within a defined pH window, kept reliably sterile and endotoxin-free, and protected against degradation across long, hot supply chains. Choosing a Citicoline Sodium Injection manufacturer that treats hygroscopic-API handling, dose uniformity and sterility assurance as core engineering disciplines is what keeps a neurology supply chain dependable.
What Sets a World-Class Citicoline Sodium Injection Manufacturer Apart
A world-class manufacturer of Citicoline Sodium Injection invests in three areas that weaker suppliers underfund: humidity-controlled formulation, precision low-variability filling, and a stability and sterility programme designed for real-world distribution. Humidity-controlled formulation begins before the batch is compounded — the hygroscopic citicoline sodium active is stored, dispensed and weighed under controlled relative humidity, with moisture content verified so that the assayed potency entering the batch matches the potency the label promises. Validated dissolution into large water-for-injection batches, in-process assay at multiple points, and controlled fill-volume checks then ensure that the first and last container of a run carry the same accurate dose — a non-negotiable when a fixed milligram dose is calculated against a stroke patient's clinical status.
Precision filling and sterility assurance matter because Citicoline Sodium Injection is so often given to acutely ill, sometimes immunocompromised patients. World-class plants compound the bulk solution under a nitrogen blanket, hold and verify pH within the target band, minimise warm hold times, and validate the terminal moist-heat sterilisation cycle so that microbial lethality is achieved without unacceptable degradation of the active. Bacterial endotoxin is controlled rigorously through depyrogenated components and validated water-for-injection systems, because a febrile reaction in a stroke or head-injury patient is a serious adverse event. All of this is captured in electronic batch records that lock deviations the moment they occur, and reinforced by 100% container leak and integrity inspection from filling through to final packaging.
Quality Systems Behind Every Citicoline Sodium Injection
Every Farbe Firma Citicoline Sodium Injection batch is released only after a full stack of quality checks: identity and assay by validated stability-indicating HPLC against USP, BP, IP or EP reference standards, related-substances profiling to keep degradation products within monograph limits, pH, particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and content-uniformity testing appropriate to a parenteral. Certificates of analysis are issued with full traceability back to API lot, excipient lot, primary-packaging lot and the qualified person responsible for release.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental and humidity monitoring, calibrated sterilisation and depyrogenation equipment, validated terminal moist-heat cycles with load mapping, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Stability is tracked under both long-term (30 °C / 65 % RH) and accelerated (40 °C / 75 % RH) ICH Q1A conditions — Zone IVb included — so we can assure customers that the Citicoline Sodium Injection they buy today will still meet specification when it reaches the patient months later in any climate.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Citicoline Sodium Injection Manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables across neurology, critical-care, emergency-medicine, metabolic and supportive-care categories. For Citicoline Sodium Injection specifically, we supply the 250 mg/2 mL, 500 mg/4 mL and 1000 mg/4 mL strengths in ampoule and vial presentations as standard, with custom strengths, fill volumes and pack configurations available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier ready to hand for registration in the buyer's target market.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability packages, translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics to the destination. When a buyer needs Citicoline Sodium Injection on a tight deadline — and neurology-programme stock often is time-critical — our regulatory, manufacturing and logistics teams move as one: dossier, artwork, production slot and shipment plan delivered as a single coordinated package, with a single accountable point of contact.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor; our quality unit answers technical queries with primary data, not slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through formulation, hygroscopic-API handling, pH control, sterilisation strategy, container-closure and stability choices in real detail. For a neuroprotective parenteral where dose accuracy and sterility influence patient outcomes, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Citicoline Sodium Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Citicoline Sodium Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, qualified ampoule and vial filling lines, qualified water-for-injection systems and validated environmental monitoring. WHO-GMP, USP, BP, IP and EP compliance documentation is available on request.
Which strengths and pack sizes of Citicoline Sodium Injection do you supply?
Our standard presentations are citicoline 250 mg/2 mL, 500 mg/4 mL and 1000 mg/4 mL as clear sterile solutions in ampoules and single-dose vials for intravenous and intramuscular use. Custom strengths, fill volumes, ampoule and vial formats and country-specific pack configurations are available under contract manufacturing agreements — share your specification and our technical team will quote within 48 hours.
Can Farbe Firma support country-specific registrations for Citicoline Sodium Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability packages (long-term and accelerated), and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. Our regulatory team has supported registrations across 30+ countries in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
How does Farbe Firma handle the hygroscopic citicoline sodium active during manufacturing?
Citicoline sodium API is markedly hygroscopic, so it is stored, dispensed and weighed under controlled relative humidity, with moisture content verified so that the potency entering each batch is accurate. The bulk solution is compounded under a nitrogen blanket at a controlled pH, and the terminal moist-heat sterilisation cycle is validated against a defined degradation budget. Identity, assay and related substances are confirmed on every batch by validated stability-indicating HPLC methods.
What is the minimum order quantity for Citicoline Sodium Injection contract manufacturing?
MOQs vary by strength, label complexity and dossier requirements. For the standard 250 mg, 500 mg and 1000 mg ampoule and vial presentations we accommodate hospital-scale and full-tender-scale orders. Contact director@farbefirma.org for a specific quotation against your specification.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments